|1.||Wang, Clay C C: 2 articles (11/2008 - 06/2008)|
|2.||Chang, Jiunn-Kae: 2 articles (11/2008 - 06/2008)|
|3.||Chiang, Yi-Ming: 2 articles (11/2008 - 06/2008)|
|4.||Hsu, Ya-Ling: 2 articles (11/2008 - 06/2008)|
|5.||Kuo, Po-Lin: 2 articles (11/2008 - 06/2008)|
|6.||Wiart, Christophe: 1 article (08/2012)|
|1.||Urinary Bladder Neoplasms (Bladder Cancer)
11/01/2008 - "Thus, the present study reports, for the first time, that induction of p21 and the Fas/mFas ligand apoptotic system may participate in the antiproliferative action of norsolorinic acid in T24 human bladder cancer cells."
11/01/2008 - "The aim of the present study was to investigate the antiproliferative activity of norsolorinic acid in T24 human bladder cancer cells. "
08/01/2012 - "A note on the relevance of norsolorinic acid as a chemopreventive agent for the treatment of bladder cancer."
11/01/2008 - "1. Norsolorinic acid, isolated from Aspergillus nidulans, has been shown to have antiproliferative activity in T24 human bladder cancer cells by arresting the cell cycle at the G(0)/G(1) phase and inducing apoptosis. "
11/01/2008 - "Norsolorinic acid inhibits proliferation of T24 human bladder cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas/membrane-bound Fas ligand-mediated apoptotic pathway."
06/01/2008 - "Norsolorinic acid, isolated from the Aspergillus nidulans, was investigated for its antiproliferative activity in human breast adenocarcinoma MCF-7 cells. "
06/01/2008 - "Norsolorinic acid from Aspergillus nidulans inhibits the proliferation of human breast adenocarcinoma MCF-7 cells via Fas-mediated pathway."
|1.||Fas Ligand Protein (Fas Ligand)